The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
Abstract
We performed field trials in the course of an epidemic in Finland to learn whether Group A memingococcal capsular polysaccharide vaccine protects infants and young children from meningitis. The first trial involved 130,178 children between the ages of three months and five years; 49,295 children received the vaccine, 48,977 received a control Haemophilus influenzae Type b polysaccharide vaccine, and 31.906 remained unvaccinated. No cases of meningitis or sepsis caused by Group A meningococci were seen in the first year of observation among the children vaccinated with meningococcal vaccine whereas six occurred among those vaccinated with the H. influenzae vaccine and 13 among those not vaccinated. In the second trial 21,007 children of the same ages received the meningococcal vaccine. No cases caused by Group A occurred among those vaccinated, although five to seven would have been expected within the year. Meningococcal Group A vaccine appears efficacious in young infants and children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine
Artenstein, M. S., Gold, R., Zimmerly, J. G., Wyle, F. A., Schneider, H., & Harkins, C. (1970) · New England Journal of Medicine · doi:10.1056/nejm197002192820803 · Cited by 369
Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.
Gold, R., Lepow, M. L., Goldschneider, I., Draper, T. L., & Gotschlich, E. C. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108235 · Cited by 235
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1385 · Cited by 199
Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type b
Anderson, P. W., Peter, G., Johnston, R. B., Wetterlow, L. H., & Smith, D. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106794 · Cited by 138
THE SURVIVAL TIME FOR DIFFERENT BACTERIA IN VARIOUS TRANSPORT MEDIA
Gästrin, B., Kallings, L. O., & MARCETIC, A. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03490.x · Cited by 122
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.
Gold, R., & Artenstein, M. S. (1971) · Europe PMC (PubMed Central) · Cited by 121
Rodrigues, L. P., Schneerson, R., & Robbins, J. B. (1971) · PubMed · Cited by 45
Cited by
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 472
Oftung, F., Løvik, M., Andersen, S. R., Frøholm, L. O., & Bjune, G. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01374.x · Cited by 21
Metadata
- Authors
- Peltola, H., Mäkelä, P. H., Käyhty, H., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O.-V., Pettay, O., Karanko, V., Ahvonen, P., & Sarna, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1977-09-29
- Volume
- 297
- Issue
- 13
- Pages
- 686-691
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2092326939
- Cited by
- 344
- References
- 8
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age. https://app.cochat.ai/papers/10.1056/nejm197709292971302
- The paper
- Peltola, H., Mäkelä, P. H., Käyhty, H., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O.-V., Pettay, O., Karanko, V., Ahvonen, P., & Sarna, S. (1977). Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age. New England Journal of Medicine. https://doi.org/10.1056/nejm197709292971302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.